Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Hesperidin methylchalcone is a semi-synthetic derivative of hesperidin, a flavonoid found in citrus fruits. Its use for supporting or treating varicose veins is justified by scientific evidence, primarily from clinical studies conducted in Europe, where it is often included in “venoactive” or “phlebotropic” drug formulations. These formulations frequently combine hesperidin methylchalcone with other flavonoids such as diosmin and are used to manage symptoms of chronic venous insufficiency (CVI), which includes varicose veins.

Randomized controlled trials and meta-analyses have shown that hesperidin methylchalcone, particularly in combination with diosmin, can reduce symptoms such as pain, heaviness, and edema in patients with CVI. The mechanism is believed to involve strengthening capillary resistance, reducing vascular permeability, and exerting anti-inflammatory effects on the venous system.

However, most clinical studies feature hesperidin methylchalcone as part of a combination therapy, making it difficult to attribute effects solely to this compound. While the evidence is stronger for the combination products, some pharmacological studies suggest that hesperidin methylchalcone alone may contribute to improved venous tone and capillary protection. Guidelines from European vascular societies often recommend venoactive drugs, including those containing hesperidin methylchalcone, as adjunctive therapy for venous disorders.

In summary, hesperidin methylchalcone is scientifically validated as part of combination therapies for varicose veins and related venous conditions, though the evidence for its solo efficacy is somewhat limited.

More about Hesperidin methylchalcone
More about Varicose Veins

Other ingredients used for Varicose Veins

Other health conditions supported by Hesperidin methylchalcone

Products containing Hesperidin methylchalcone